Literature DB >> 4802631

The potential role of immunological adjuvants in influenza vaccines.

D Hobson.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4802631      PMCID: PMC2495378          DOI: 10.1136/pgmj.49.569.180

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  15 in total

1.  SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.

Authors:  D HOBSON; C A LANE; A S BEARE; C P CHIVERS
Journal:  Br Med J       Date:  1964-08-01

2.  FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.

Authors:  W J HERBERT; S SELWYN; J R PHILP
Journal:  Br J Prev Soc Med       Date:  1965-04

3.  Serological responses and clinical reactions to influenza virus vaccines.

Authors:  F HIMMELWEIT
Journal:  Br Med J       Date:  1960-12-10

4.  Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule.

Authors:  A V HENNESSY; F M DAVENPORT
Journal:  Public Health Rep       Date:  1961-05       Impact factor: 2.792

5.  Applied immunology of mineral oil adjuvants.

Authors:  F M DAVENPORT
Journal:  J Allergy       Date:  1961 May-Jun

6.  Gross physical properties of emulsified influenza virus vaccines and the adjuvant response.

Authors:  B S BERLIN
Journal:  J Immunol       Date:  1960-07       Impact factor: 5.422

7.  A study of the effectiveness of influenza vaccination in an industrial population.

Authors:  F W MEICHEN; E ROGAN; R W HOWELL
Journal:  Br J Ind Med       Date:  1962-07

8.  The clinical application of adjuvant 65.

Authors:  M R Hilleman; A Woodhour; A Friedman; R E Weibel; J Stokes
Journal:  Ann Allergy       Date:  1972-03

9.  Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.

Authors:  D S Fedson; R V Fulk; M A Huber; M A Reisberg; J A Kasel
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

10.  New metabolizable immunologic adjuvant for human use. 5. Evaluation of highly purified influenza-virus vaccine in adjuvant 65.

Authors:  R E Weibel; A F Woodhour; J Stokes; D P Metzgar; M R Hilleman
Journal:  N Engl J Med       Date:  1967-01-12       Impact factor: 91.245

View more
  1 in total

1.  The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.

Authors:  C R Crawford; R Jennings; N Bradford; C W Potter
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.